Pimecrolimus and Atorvastatin calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pimecrolimus (pimecrolimus) and Atorvastatin calcium (atorvastatin calcium). Common drug interactions include lymphadenopathy among females and pruritus among males.

The phase IV clinical study analyzes what interactions people have when they take Pimecrolimus and Atorvastatin calcium. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Pimecrolimus?

Pimecrolimus has active ingredients of pimecrolimus. eHealthMe is studying from 1,358 Pimecrolimus users. Check the latest studies of Pimecrolimus.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.



On Jul, 16, 2026

23 people who take Pimecrolimus and Atorvastatin calcium together, and have interactions are studied.

Pimecrolimus and Atorvastatin calcium drug interactions.

What are the common drug interactions of Pimecrolimus and Atorvastatin Calcium, by gender? *:

female:

  1. Lymphadenopathy (disease or enlargement of lymph nodes)
  2. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  3. Pruritus (severe itching of the skin)
  4. Cough
  5. Diarrhoea
  6. Drug ineffective
  7. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  8. Stasis dermatitis (skin inflammation caused by blood pooling in the veins in your legs)
  9. Upper respiratory tract infection
  10. Abdominal pain

male:

  1. Pruritus (severe itching of the skin)
  2. Erythema (redness of the skin)
  3. Injection site haemorrhage (bleeding from injection site)
  4. Injection site pain
  5. Injection site swelling
  6. Rash
  7. Surgery
  8. Visual impairment
  9. Lacrimation increased
  10. Ocular hyperaemia (an abnormally large amount of blood in eye)

What are the common drug interactions of Pimecrolimus and Atorvastatin Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  3. Drug ineffective
  4. Haematochezia (passage of stools containing blood)
  5. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

50-59:

  1. Erythema (redness of the skin)
  2. Pruritus (severe itching of the skin)
  3. Drug ineffective
  4. Rash

60+:

  1. Lymphadenopathy (disease or enlargement of lymph nodes)
  2. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  3. Dizziness
  4. Drug ineffective
  5. Dry eye (lack of adequate tears)
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  7. Eye pain
  8. Eye pruritus (eye itching)
  9. Eye swelling
  10. Fall

What are the existing conditions these people have? *

  1. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 12 people, 52.17%
  2. Pinguecula (slightly elevated elastic tissue deposit in the conjunctiva): 2 people, 8.70%
  3. Osteoporosis (bones weak and more likely to break): 2 people, 8.70%
  4. House Dust Allergy: 2 people, 8.70%
  5. Gastritis (inflammation of stomach): 2 people, 8.70%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 8.70%
  7. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 8.70%
  8. Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 8.70%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 8.70%
  10. Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Pimecrolimus and Atorvastatin calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pimecrolimus and Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pimecrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pimecrolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atorvastatin calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pimecrolimus and atorvastatin calcium (the active ingredients of Pimecrolimus and Atorvastatin calcium, respectively), and Pimecrolimus and Atorvastatin calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: